Hint mode is switched on Switch off
For swift navigation between sections

Polyrizon

PDF download

Choose all Reset all
Download Cancel
Organization name
Polyrizon Ltd.
Country name
USA
Country of registration
Israel
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Polyrizon Ltd operates as a development stage biotech company. The Company focuses on the development and commercialization of intranasal care products that helps to protect against viruses and allergens from contacting the nasal epithelial tissue. Polyrizon serves customers in Israel.

Awards

News

29/10/2024 Polyrizon Shares Sink in Nasdaq Debut
29/10/2024 Polyrizon Prices $4.2 Million IPO
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001893645
Registration is required to get access.